Dynavax Technologies Stock Annual Yield

DVAX Stock

USD 12.91 0.25 1.97%

Dynavax Technologies fundamentals help investors to digest information that contributes to Dynavax Technologies' financial success or failures. It also enables traders to predict the movement of Dynavax Stock. The fundamental analysis module provides a way to measure Dynavax Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dynavax Technologies stock.

Total Liab Other Stockholder Equity

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Dynavax Technologies Company Annual Yield Analysis

Dynavax Technologies' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.

Yield

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

Dynavax Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for Dynavax Technologies is extremely important. It helps to project a fair market value of Dynavax Stock properly, considering its historical fundamentals such as Annual Yield. Since Dynavax Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dynavax Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dynavax Technologies' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Total Current Assets	Net Receivables	Good Will	Intangible Assets	Long Term Debt	Short Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.85	-0.49	0.86	0.13	0.8	0.19	0.91	0.62	0.11	0.97	0.84	-0.57	-0.1	0.87	-0.3	0.83	0.78	0.77	0.81	-0.61	0.86	0.9	0.93
Total Stockholder Equity	0.85		-0.21	0.48	0.04	0.96	0.21	0.61	0.2	0.18	0.93	0.59	-0.54	-0.16	0.61	-0.14	0.99	0.59	0.52	0.59	-0.74	0.87	0.94	0.73
Retained Earnings	-0.49	-0.21		-0.63	-0.67	-0.26	0.02	-0.74	-0.39	-0.36	-0.41	-0.41	0.46	-0.1	-0.7	0.7	-0.11	-0.83	-0.74	-0.8	0.12	-0.27	-0.25	-0.57
Total Liab	0.86	0.48	-0.63		0.19	0.43	0.12	0.95	0.85	0.01	0.75	0.84	-0.44	-0.01	0.88	-0.37	0.45	0.74	0.8	0.8	-0.32	0.62	0.61	0.87
Accounts Payable	0.13	0.04	-0.67	0.19		0.17	-0.08	0.36	-0.1	0.54	0.14	-0.03	-0.4	0.15	0.41	-0.42	-0.02	0.55	0.5	0.55	-0.07	0.09	0.06	0.19
Short Term Investments	0.8	0.96	-0.26	0.43	0.17		0.2	0.59	0.07	0.4	0.91	0.44	-0.54	-0.1	0.66	-0.13	0.96	0.6	0.6	0.61	-0.84	0.81	0.94	0.72
Common Stock	0.19	0.21	0.02	0.12	-0.08	0.2		0.09	0.15	-0.01	0.19	0.19	0.5	-0.17	0.09	0.52	0.19	0.05	0.05	-0.03	0.0	0.19	0.12	0.17
Property Plant Equipment	0.91	0.61	-0.74	0.95	0.36	0.59	0.09		0.72	0.15	0.83	0.77	-0.6	-0.09	0.91	-0.48	0.57	0.86	0.84	0.91	-0.47	0.67	0.72	0.9
Current Deferred Revenue	0.62	0.2	-0.39	0.85	-0.1	0.07	0.15	0.72		-0.47	0.46	0.73	-0.15	-0.11	0.51	-0.23	0.18	0.45	0.4	0.49	-0.02	0.36	0.32	0.58
Net Debt	0.11	0.18	-0.36	0.01	0.54	0.4	-0.01	0.15	-0.47		0.2	-0.14	-0.23	0.14	0.46	-0.11	0.18	0.36	0.54	0.36	-0.36	0.18	0.25	0.31
Total Current Assets	0.97	0.93	-0.41	0.75	0.14	0.91	0.19	0.83	0.46	0.2		0.71	-0.59	-0.09	0.82	-0.24	0.92	0.73	0.74	0.76	-0.75	0.87	0.97	0.89
Net Receivables	0.84	0.59	-0.41	0.84	-0.03	0.44	0.19	0.77	0.73	-0.14	0.71		-0.39	-0.12	0.72	-0.25	0.55	0.63	0.59	0.68	-0.14	0.75	0.57	0.81
Good Will	-0.57	-0.54	0.46	-0.44	-0.4	-0.54	0.5	-0.6	-0.15	-0.23	-0.59	-0.39		-0.05	-0.57	0.54	-0.51	-0.53	-0.55	-0.66	0.57	-0.45	-0.59	-0.5
Intangible Assets	-0.1	-0.16	-0.1	-0.01	0.15	-0.1	-0.17	-0.09	-0.11	0.14	-0.09	-0.12	-0.05		0.09	-0.09	-0.15	0.03	0.31	-0.05	0.01	-0.13	-0.11	-0.14
Long Term Debt	0.87	0.61	-0.7	0.88	0.41	0.66	0.09	0.91	0.51	0.46	0.82	0.72	-0.57	0.09		-0.4	0.59	0.85	0.97	0.89	-0.51	0.71	0.74	0.94
Short Term Debt	-0.3	-0.14	0.7	-0.37	-0.42	-0.13	0.52	-0.48	-0.23	-0.11	-0.24	-0.25	0.54	-0.09	-0.4		-0.07	-0.61	-0.41	-0.58	0.05	-0.17	-0.14	-0.31
Net Tangible Assets	0.83	0.99	-0.11	0.45	-0.02	0.96	0.19	0.57	0.18	0.18	0.92	0.55	-0.51	-0.15	0.59	-0.07		0.53	0.49	0.54	-0.77	0.86	0.95	0.71
Capital Surpluse	0.78	0.59	-0.83	0.74	0.55	0.6	0.05	0.86	0.45	0.36	0.73	0.63	-0.53	0.03	0.85	-0.61	0.53		0.83	0.96	-0.31	0.73	0.61	0.84
Deferred Long Term Liab	0.77	0.52	-0.74	0.8	0.5	0.6	0.05	0.84	0.4	0.54	0.74	0.59	-0.55	0.31	0.97	-0.41	0.49	0.83		0.85	-0.49	0.6	0.65	0.83
Long Term Debt Total	0.81	0.59	-0.8	0.8	0.55	0.61	-0.03	0.91	0.49	0.36	0.76	0.68	-0.66	-0.05	0.89	-0.58	0.54	0.96	0.85		-0.37	0.73	0.66	0.88
Short Long Term Debt	-0.61	-0.74	0.12	-0.32	-0.07	-0.84	0.0	-0.47	-0.02	-0.36	-0.75	-0.14	0.57	0.01	-0.51	0.05	-0.77	-0.31	-0.49	-0.37		-0.46	-0.85	-0.5
Net Invested Capital	0.86	0.87	-0.27	0.62	0.09	0.81	0.19	0.67	0.36	0.18	0.87	0.75	-0.45	-0.13	0.71	-0.17	0.86	0.73	0.6	0.73	-0.46		0.85	0.85
Net Working Capital	0.9	0.94	-0.25	0.61	0.06	0.94	0.12	0.72	0.32	0.25	0.97	0.57	-0.59	-0.11	0.74	-0.14	0.95	0.61	0.65	0.66	-0.85	0.85		0.82
Capital Stock	0.93	0.73	-0.57	0.87	0.19	0.72	0.17	0.9	0.58	0.31	0.89	0.81	-0.5	-0.14	0.94	-0.31	0.71	0.84	0.83	0.88	-0.5	0.85	0.82

Click cells to compare fundamentals

Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.

Competition

Predict Dynavax Technologies

In accordance with the recently published financial statements, Dynavax Technologies has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Portfolio Analyzer Now

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine

All Next

Launch Module

Dynavax Technologies ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Dynavax Technologies' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Dynavax Technologies' managers, analysts, and investors.

Environmental

Governance

Social

Dynavax Fundamentals

	Return On Equity	0.0318
	Return On Asset	-0.0038
	Profit Margin	0.08 %
	Operating Margin	0.15 %
	Current Valuation	1.18 B
	Shares Outstanding	131.46 M
	Shares Owned By Insiders	0.33 %
	Shares Owned By Institutions	99.67 %
	Number Of Shares Shorted	21 M
	Price To Earning	6.95 X
	Price To Book	2.49 X
	Price To Sales	6.48 X
	Revenue	232.28 M
	Gross Profit	448.22 M
	EBITDA	9.67 M
	Net Income	(6.39 M)
	Cash And Equivalents	518.17 M
	Cash Per Share	4.10 X
	Total Debt	256.91 M
	Debt To Equity	0.61 %
	Current Ratio	2.77 X
	Book Value Per Share	5.19 X
	Cash Flow From Operations	100.56 M
	Short Ratio	6.76 X
	Earnings Per Share	0.15 X
	Target Price	24.6
	Number Of Employees	408
	Beta	1.34
	Market Capitalization	1.69 B
	Total Asset	997.1 M
	Retained Earnings	(930.58 M)
	Working Capital	796.92 M
	Current Asset	199.95 M
	Current Liabilities	28.79 M
	Net Asset	997.1 M

About Dynavax Technologies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Dynavax Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dynavax Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dynavax Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC